Document is current
Any future updates will be listed below
-
Authors
Kjær, Birgitte Hougs http://orcid.org/0000-0002-1045-2137
Cools, Ann M.
Johannsen, Finn E.
Trøstrup, Jeanette
Bieler, Theresa
Siersma, Volkert
Magnusson, Peter S.
-
Funding
Funding for this research was provided by:
Region Hovedstaden (A6932)
Lundbeck Foundation (no number)
Bispebjerg Hospital (Internal fund)
Fonden for Almen Praksis (A3588)
Danske Fysioterapeuter (no number)
Gigtforeningen (R192-A6751)
Copenhagen University
- License Information
-
More Information
Article History
Received: 9 December 2023
Accepted: 6 February 2024
First Online: 21 February 2024
Declarations
:
: The PASE trial has been approved by the Capital Regions Research Ethics Committee (H-19050820) on 25 August 2021 and the Danish Data Protection Agency (P-2021–536) on 4 August 2021 and will be performed in accordance with the Declaration of Helsinki. The study has been prospectively registered in ClinicalTrials.gov identifier NCT05124769 on August 11, 2021, before inclusion of the first participant. Participation in the study is voluntary. Written, informed consent to participate will be obtained from all participants. All data and information collected during the trial will be treated confidentially and stored according to the requirement of the Danish Data Protection Agency. Any modification to the protocol, which may impact the study or the patient’s health, will be approved by the Capital Regions Research Ethics Committee and the Danish Protection Agency.
